Infinity Announces the Date of Its Full-Year 2016 Financial Results Conference Call and Webcast

Loading...
Loading...

CAMBRIDGE, Mass., Feb. 28, 2017 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. INFI will host a conference call on Tuesday, March 14, 2017, at 4:30 p.m. ET to review its full-year 2016 financial results and provide an update on the company.

A live webcast of the conference call can be accessed in the Investors/Media section of Infinity's website at www.infi.com. To participate in the conference call, please dial 1-877-316-5293 (domestic) and 1-631-291-4526 (international) five minutes prior to start time. The conference ID number is 64141040. An archived version of the webcast will be available on Infinity's website for 30 days.

About Infinity
Infinity is an innovative biopharmaceutical company dedicated to advancing novel medicines for people with cancer. Infinity is advancing IPI-549, an oral immuno-oncology development candidate that selectively inhibits PI3K-gamma. A Phase 1 study in patients with advanced solid tumors is ongoing. For more information on Infinity, please refer to Infinity's website at www.infi.com.

Contact:
Jaren Irene Madden, Senior Director,
Investor Relations and Corporate Communications
617-453-1336 or Jaren.Madden@infi.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/infinity-announces-the-date-of-its-full-year-2016-financial-results-conference-call-and-webcast-300413328.html

SOURCE Infinity Pharmaceuticals, Inc.

Posted In: Press Releases
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...